Market Overview

Cantor Fitzgerald Reiterates Hold Rating, $29 PT for Centene

Related CNC
UBS Says Centene Faces No Weakness In Fundamentals, Despite Shakiness In Shares
Mid-Afternoon Market Update: Gold Futures Up 2%; CoLucid Shares Climb After Migraine Drug Achieves Primary And Key Secondary Endpoints
ObamaCare's Individual Mandate Bites Hardest In These Cities (Investor's Business Daily)

In a report published earlier today, Cantor Fitzgerald L.P. reiterated its Hold rating and $29.00 price target for Centene Corp. (NYSE: CNC).

Cantor Fitzgerald went on to say “Centene's earnings shortfall is a big psychological blow to the Medicaid names, which have surged on the expectation that the increased application of managed care to complex cases will boost the sector's business, but earnings have lagged. This raises concern about its ability to capitalize on the industry's growth in other new and larger markets.”

Centene Corp. closed yesterday at $28.20.

Latest Ratings for CNC

Oct 2016Credit SuisseMaintainsOutperform
Sep 2016Evercore ISI GroupInitiates Coverage onBuy
Sep 2016Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Reiteration Analyst Ratings


Related Articles (CNC)

View Comments and Join the Discussion!